We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Qimonda AG Ads | NYSE:QI | NYSE | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
March 10, 2015
Quintiles CEO Tom Pike will present at the 2014 Barclays Global Healthcare Conference on Tuesday, March 10, 2015 in Miami at the Loews Miami Hotel.
Quintiles CEO Tom Pike (Photo: Business Wire)
The Quintiles presentation will begin at 11:15 a.m. (EST). Investors may access a live audio webcast of the presentation on the Quintiles Investor Relations website at www.quintiles.com/investors. An archived audio version of the presentation will be available later that day.
About Quintiles
Quintiles (NYSE:Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top-100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150227005019/en/
QuintilesPhil Bridges, Media Relations+1-919-998-1653mobile: +1-919-457-6347phil.bridges@quintiles.comorKarl Deonanan, Investor Relations+1-919-998-2789InvestorRelations@quintiles.com
1 Year Qimonda AG Ads Chart |
1 Month Qimonda AG Ads Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions